Table 1.
Comparison of study groups
| Group 1 | Group 2 | Group 3 | |
|---|---|---|---|
| Number of participants | 50 | 50 | 50 |
| Sex (M/F) | 58/42 | 54/46 | 48/52 |
| Average age (years) | 47 ± 10 | 53 ± 9 | 52 ± 9 |
| Average duration of diabetes mellitus (in year) | - | 6.3 ± 2.8 | 8.2 ± 3.8 |
| FBS (mg/dl) | 94 ± 11 | 129 ± 39 | 188 ± 86 |
| PP2BS (mg/dl) | 119 ± 11 | 184 ± 57 | 271 ± 109 |
| Serum creatinine (mg/dl) | 0.89 ± 0.20 | 0.96 ± 0.19 | 1.03 ± 0.29 |
| Serum total protein (gm/dl) | 6.8 ± 0.6 | 6.8 ± 0.5 | 6.7 ± 0.5 |
| Serum albumin (gm/dl) | 4.3 ± 0.3 | 4.4 ± 0.3 | 4.3 ± 0.3 |
| Serum total cholesterol (mg/dl) | 174 ± 35 | 177 ± 37 | 184 ± 43 |
| Serum LDL cholesterol (mg/dl) | 121 ± 29 | 117 ± 27 | 121 ± 27 |
| Urinary protein/creatinine (mg/g) | 11 ± 9 | 18 ± 8 | 140 ± 161 |
| Serum fructosamine (μmol/l) | 253 ± 24 | 313 ± 58 | 395 ± 119 |
| Serum glycated albumin (μmol/l) | 136 ± 26 | 162 ± 42 | 202 ± 78 |
| Serum glycated β-lipoprotein (μmol/l) | 25.2 ± 5.1 | 32.8 ± 7.8 | 50.4 ± 11.6 |